Back to Journals » Drug Design, Development and Therapy » Volume 9

Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran

Total article views   HTML views PDF downloads Totals
18,820 Dovepress* 16,132+ 1,732 17,864
PubMed Central* 2,688 761 3,449
Totals 18,820 2,493 21,313
*Since 9 July 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 1 0 0 1 2

View citations on PubMed and Google Scholar